Understanding the Market | BRAINAURORA-B Rises Over 14% as the Brain-Computer Interface Industry Welcomes Policy Catalysts; The Company's Cognitive Impairment Digital Therapy Products Have a First-Mover Advantage

BRAINAURORA-B's stock price rose over 14%, closing at HKD 8.5, with a trading volume of HKD 311 million. Li Lecheng, the Minister of Industry and Information Technology, stated at the China International Industry Fair that he will promote the development of emerging industries, and the brain-computer interface industry is receiving policy support. The National Medical Products Administration has released industry standards for brain-computer interface medical devices, laying the foundation for industrial development. BRAINAURORA's cognitive impairment digital therapy product is the first medical-grade product in China to receive regulatory approval and has been included in the medical insurance reimbursement catalog, aiding market promotion